Navigation Links
Adolor in Medical News

Michael J. Fox Foundation Awards $3.8 Million To Drive Nine Industry Partnerships For Pre-Clinical Parkinson's Drug Development

...th Carolina Optimization of MOR antagonists for the treatment of L-DOPA-induced dyskinesias in Parkinson's disease Patrick Little, PhD, adolor Corporation, Exton, Pennsylvania TDI is launched bi-annually with applications accepted each spring and fall. It has been enthusiastically re...

BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX

...ay's Trade Alerts include: DUSA Pharmaceuticals Inc. (Nasdaq: DUSA ), MiddleBrook Pharmaceuticals Inc. (Nasdaq: MBRK ), NovaMed Inc. (Nasdaq: NOVA), adolor Corp. (Nasdaq: ADLR ), Affymetrix Inc. (Nasdaq: AFFX ) and Abaxis Inc. (Nasdaq: ABAX ). Join investor discussion surrounding these stocks at: ht...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...q: THRX ) United Therapeutics Corp. (Nasdaq: UTHR ) Valeant Pharmaceuticals Int'l (NYSE: VRX ) Vertex Pharmaceuticals (Nasdaq: VRTX ) Add adolor Corp. (Nasdaq: ADLR ) ALLOS THERAPEUTICS INC. (Nasdaq: ALTH ) Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY ) Alpharma Inc. (NYSE: ALO ) Altu...
Adolor in Medical Technology

GSK and Adolor Announce Preliminary Results from Phase 3 Safety Study of Alvimopan (Entereg/Entrareg)

LONDON & EXTON, Pa.--(BUSINESS WIRE)--Apr 9, 2007 - GlaxoSmithKline (LSE and NYSE:GSK) and Adolor Corporation (Nasdaq:ADLR) today announced data from Study 767905/014 and provided an update on the clinical development program for alvimopan (Entereg/Entrareg(R)). Study 014, a Phase 3, double bl...
Adolor in Biological Technology

Beacon Equity Issues Technical Trade Alerts on Drug Manufacturer Stocks: FRX, TEVA, AGN, CEPH, VRTX, ADLR

...al Industries Ltd. (Nasdaq: TEVA ), Allergan Inc. (NYSE: AGN ), Cephalon Inc. (Nasdaq: CEPH ), Vertex Pharmaceuticals Inc. (Nasdaq: VRTX ) and adolor Corp. (Nasdaq: ADLR ). Join the fastest growing investment community at: http://www.stockhideout.com See what Cramer has to say about...

Adolor Corporation to Host Investor Conference Call to Report 2008 Financials and Provide an Update on the Launch of ENTEREG(R) (alvimopan)

... EXTON, Pa., Feb. 18 /PRNewswire-FirstCall/ -- adolor Corporation (Nasdaq: ADLR ) today announced that...play will be available for one week. About adolor Corporation adolor Corporation is a biopharmaceutical company special...

Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...AY INDS INC (Tokyo SE: 3402) TOYOBO CO (Tokyo SE: 3101) VALEANT PHARMACEUTICALS INTL (NYSE: VRX ) HealthShares(TM) Composite Index (HHQ) Drop adolor CORPORATION (NASDAQ: ADLR ) ALEXION PHARMACEUTICALS INC. (NASDAQ: ALXN ) ALKERMES INC. (NASDAQ: ALKS ) ALLERGAN INC. (NYSE: AGN ) ALLOS THERAP...

Premier Research Names Anthony Faragasso, MD as Executive Director and Global Head of Medical Management and Safety

...rgen, Inc.; Centocor, Inc.; OmniCare (formerly IBAH-BioPharm); Pharmacia-Upjohn, and MDS Pharma Services. Dr. Faragasso comes to Premier Research from adolor Corporation where he established and managed a successful and growing safety department over the last 7 years. "We are very pleased to have Dr. Fara...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)

...asdaq: THRX ) United Therapeutics Corp. (Nasdaq: UTHR ) Valeant Pharmaceuticals Int'l (NYSE: VRX ) Vertex Pharmaceuticals (Nasdaq: VRTX ) Add adolor Corp. (Nasdaq: ADLR ) ALLOS THERAPEUTICS INC. (Nasdaq: ALTH ) Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY ) Alpharma Inc. (NYSE: ALO ) Altus Ph...

NeurogesX Appoints New Director to the Board

...ttle Clinic, a start-up medical care services company. Prior to that, Mr. Peacock served as President and Chief Executive Officer and as a director of adolor Corporation, President, CEO, COO and as a director of Orthovita, Inc., Executive Vice President, Chief Operating Officer and as a director of Cephalon...

The Generic Drug Industry in Illinois

...ide pharmaceuticals for Novartis from 1998 to 2000 and chairman of the Novartis BioVenture Fund, and CEO Andrew Reddick, who was previously the COO of adolor and had been a senior executive with Faulding). It is clear that all these companies and their investors see the potential growth of the U.S. gene...
Other Tags
(Date:7/25/2014)... July 25, 2014 As reported by Wood ... Deaths Increase (7/20), Michigan has seen a nearly 500-person increase ... While the count was 271 between 1999 and 2002, the ... Agents believe that, like other states, drug users in Michigan ... via prescription pills. He compared the price of both substances, ...
(Date:7/25/2014)... Florida Hospital and MOSI officially announced a transformational partnership ... come and make a difference in the Tampa Bay community. ... to provide the support needed to keep the science center ... the IMAX Dome Theatre from film to a state-of-the-art digital ... Theatre in the state of Florida, and it is one ...
(Date:7/25/2014)... York, US (PRWEB) July 25, 2014 ... global provider of technology-enabled services for the financial, ... that its virtual data room business, Merrill DataSite, ... the Year” presented by GrowthBusiness at the M&A ... Awards recognize the achievements of entrepreneurs, management teams, ...
(Date:7/25/2014)... A new study conducted by the Hospital ... percent of all children in the survey under the age of ... at 2,505 children during the years of 2011 and 2013. The ... The final result was that about two out of every ... children were from lower-income families and were of East Asian heritage. ...
(Date:7/25/2014)... July 25, 2014 Parker Waichman LLP, ... of consumers comments on a recent tobacco lawsuit in ... smoker $23.6 billion in punitive damages. Cynthia Robinson brought ... cigarettes. The case is Cynthia Robinson v. R.J. Reynolds ... Florida First Circuit Court, Escambia County, Florida; Case Number ...
Breaking Medicine News(10 mins):Health News:Rise in Heroin Use, Overdose Deaths in Michigan 2Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 2Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 3Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 4Health News:Merrill DataSite Recognized as “Technology Provider of the Year” by GrowthBusiness at the M&A Awards 2014 Event 2Health News:North York Dental Provides Services to Toronto Children in Light of Growing Demand 2Health News:North York Dental Provides Services to Toronto Children in Light of Growing Demand 3Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 2Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 3
(Date:7/25/2014)... MOResearchers at the Stowers Institute for Medical Research ... pheromone receptors, and found pheromones crucial to triggering the ... of receptors helps a male mouse detect pheromones that ... of receptors lets him know if the female mouse ... pheromones are critical to trigger mating. Stowers, researchers believe ...
(Date:7/24/2014)... 2014) Scientists at The New York Stem ... closer to creating a viable cell replacement therapy ... , For the first time, NYSCF scientists ... skin samples of patients with primary progressive multiple ... to induce these stem cells into becoming oligodendrocytes, ...
(Date:7/24/2014)... 24, 2014) Scientists at The New York ... step closer to creating a viable cell replacement ... cells. , For the first time, NYSCF ... from skin samples of patients with primary progressive ... protocol to induce these stem cells into becoming ...
Breaking Biology News(10 mins):It takes two to court 2It takes two to court 3NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2
Other Contents